Predict your next investment

HEALTHCARE | Medical Equipment & Supplies
savsu.com

See what CB Insights has to offer

Founded Year

2009

Stage

Acquired | Acquired

Total Raised

$6M

About SAVSU Technologies

SAVSU Technologies is a designer and manufacturer of cloud-connected storage and transport containers for temperature sensitive biologics and pharmaceuticals optimized for the cell and gene therapy supply chain.

SAVSU Technologies Headquarter Location

4209 Balloon Park Rd. NE

Albuquerque, New Mexico, 87109,

United States

505-466-1962

Latest SAVSU Technologies News

BioLife Solutions Awarded Three New Patents for Cell and Gene Therapy Bioproduction Tools

Mar 2, 2020

Expanded Intellectual Property Related to 2019 Acquisitions of Astero Bio and SAVSU Technologies News provided by Share this article BOTHELL, Wash., March 2, 2020 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced three new patents for bioproduction tools related to the 2019 acquisitions of Astero Bio and SAVSU Technologies. The new patents awarded to BioLife include: United States Patent: Contents Rack for Use in Insulated Storage Containers This patent covers the key technologies used in the -80°C dry ice evo® smart shipping container, currently in use by Novartis to transport the AveXis ZOLGENSMA® gene therapy. The evo platform was acquired from SAVSU Technologies in August 2019. Japan Patent: Systems, Devices, and Methods for Automated Sample Thawing This patent covers core technologies used in the ThawSTAR® automated, water-free thaw products acquired from Astero Bio in April 2019. United States Patent: Biologic Stability, Delivery Logistics and Administration of Time and/or Temperature Sensitive Biologic Based Materials This patent covers core features in the evo.is cloud application that enables real-time tracking and monitoring of high-value shipments of cell and gene therapies. Mike Rice, BioLife Solutions CEO, remarked, "We have a remarkably strong team of inventors who are experts in the fields of cryopreservation, storage and transport, and thawing of biologic material. Our portfolio now includes a synergistic family of risk-mitigating bioproduction tools, including our CryoStor ® and HypoThermosol ® biopreservation media, ThawSTAR  automated, water-free thawing products, evo platform of smart, cloud-connected shipping containers and the evo.is cloud app, and Custom Biogenic Systems  high capacity freezers, racks and accessories. We look forward to providing a continuous stream of innovative solutions to the high growth cell and gene therapy market. "    About BioLife Solutions BioLife Solutions is a leading supplier of cell and gene therapy bioproduction tools. Our tools portfolio includes our proprietary  CryoStor®  freeze media and HypoThermosol®  shipping and storage media,  ThawSTAR ® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems  high capacity storage freezers. For more information, please visit  www.biolifesolutions.com , and follow BioLife on  Twitter . Cautions Regarding Forward Looking Statements Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company following the acquisitions of Astero Bio, SAVSU Technologies and Custom Biogenic Systems, the expected synergies between the company and the acquired companies, the company's ability to realize all or any of the anticipated benefits associated with the acquisitions, the company's ability to implement its business strategy and anticipated business and operations following the acquisitions, the potential utility of and market for its products and services, the company's anticipated future growth strategy, including the acquisition of synergistic cell and gene therapy manufacturing tools and services or technologies, anticipated business and operations, guidance for financial results in 2019 and 2020, including regarding revenue from the acquired companies, the potential utility of and market for our products and services, and potential revenue growth and market expansion, including with consideration to the acquisitions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including among other things, uncertainty regarding unexpected costs, charges or expenses resulting from the acquisitions; market adoption of the company's products or the acquired products; the ability of the acquisitions to be accretive on an adjusted EPS basis and contribute to adjusted EBITDA in 2020, the ability of the company to implement its business strategy; uncertainty regarding third-party market projections; market volatility; competition; litigation; and those other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. We undertake no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law. Media & Investor Relations

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing SAVSU Technologies

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned SAVSU Technologies in 1 CB Insights research brief, most recently on Aug 6, 2020.

Expert Collections containing SAVSU Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SAVSU Technologies is included in 6 Expert Collections, including Supply Chain & Logistics Tech.

S

Supply Chain & Logistics Tech

2,865 items

Companies offering technology-driven solutions that serve the supply chain & logistics space (e.g. shipping, inventory mgmt, last mile, trucking).

P

Pharma Supply Chain

1,258 items

R

Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

M

Medical Devices

8,341 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

9,303 items

Companies that use or incorporate digital technology into their health/wellness product & service offerings. Only those that have raised funding after 01/01/2010

P

Pharma Supply Chain in Healthcare Tech Market Map

99 items

Private companies that are addressing 11 distinct technology priorities across the pharmaceutical supply chain.

SAVSU Technologies Patents

SAVSU Technologies has filed 9 patents.

The 3 most popular patent topics include:

  • Cooling technology
  • Cryogenics
  • Industrial gases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/21/2011

12/1/2020

Thermodynamics, Cooling technology, Energy storage, Sustainable building, Vaccines

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/21/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/1/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Thermodynamics, Cooling technology, Energy storage, Sustainable building, Vaccines

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.